Sickle Cell Disease (SCD) affects approximately 100,000 individuals in the US. Despite medical advances, morbidity is high and their lifespan remains shortened. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment to date and as outcomes improve its use has increased. Complications of HSCT are frequent and some literature suggests there is a higher incidence in the SCD population. In addition, preexisting vasculopathy in this population may contribute to an increased incidence of post-transplant CNS toxicity. We present the imaging findings of HCST complications in children with SCD. Read More

Meeting name: SPR 2017 Annual Meeting & Categorical Course , 2017

Authors: Alis Jonathan, Levin Terry, Kurian Jessica, Mahadeo Kris, Taragin Benjamin

Keywords: Graft versus host disease, bone marrow transplant, HSCT